The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson
March 30, 2020 -- Forbes reports on the half billion dollar grant to J&J to create develop the COVID-19 vaccine.
That’s according to a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen, which specified a “new vaccine asset for 2019 Novel Coronavirus (COVID-19),” Forbes found. It’s the largest reported amount spent on a vaccine project to date, even though the pharma giant hasn’t yet started any clinical trials as other firms have.
Read the article on Forbes: The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson